We use cookies for a better user experience. Read our Privacy Policy

I Agree

Hematocrit Test Devices Market

Hematocrit Test Devices Market (Product - Blood Analyzers, Hematocrit Test Meters; End user - Hospital and Ambulatory Surgical Centers, Clinics, Diagnostic and Pathology Labs) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Hematocrit Test Devices Market - Snapshot

Hematocrit test devices are type of in vitro diagnostic devices. These devices are computerized and specialized machines used for counting and characterizing white blood cells, platelets, and red blood cells. New generation hematocrit test devices are bench top and have micro sampling autoloaders with continuous loading capability. Additionally, these are equipped with barcode tracking technology. Moreover, point-of-care hematocrit test meter is a wireless instrument that operates on a single-use cartridge. Normal blood analyzers can complete blood count analysis with three-level WBC differentiation. The three major physical technologies used in blood analyzers are electrical impedance, flow cytometry, and fluorescent flow cytometry. The device has gained popularity, as it helps in effective evaluation of hematocrit value compared to manual method for evaluation of hematocrit parameter. Rise in blood-related diseases among the geriatric population is likely to drive the global hematocrit test devices market in the near future.

hematocrit test devices market

The global hematocrit test devices market is characterized by increase in incidence of chronic disease induced anemia across the world. The market is witnessing gradual rise in technological advancement supported by government funding and initiatives. The global hematocrit test devices market is projected to expand at steady pace from 2018 to 2026.

Increase in the geriatric population which is prone to blood borne diseases, large patient base in developing countries demanding proper treatment and diagnosis, and investments by public and private market players in R&D on hematocrit test devices for diagnostic testing of blood and treatment of hematology originated diseases drive the global hematocrit test devices market. However, lengthy regulatory approval procedure, significant investment required in innovation of diagnostic devices and solutions, and lack of awareness about importance of hematocrit tests in the diagnosis of diseases are likely to restrain the global market during the forecast period. Hematocrit test devices are gaining popularity among health care professionals, as these have proven to be effective in producing accurate complete blood count result which help health care professional in the treatment and diagnosis of blood borne diseases. Use of hematocrit test devices reduces the inaccurate evaluation of hematocrit value using manual calculation and are found to be more effective in complete blood count test than laboratory based manual procedures. Investment in innovation in hematocrit test meters or analyzers and partnerships for co-development and commercialization of hematocrit test devices are expected to fuel the growth of the global hematocrit test devices market in the near future.

In terms of product, the global hematocrit test devices market has been classified into blood analyzers, hematocrit test meters, and others. The others segment comprises consumables and accessories of hematocrit test devices. The blood analyzers segment includes hematology analyzers and blood gas systems. The blood analyzers segment is projected to dominate the market during the forecast period. Growth of the segment can be attributed to increase in usage of blood analyzers for various tests such as white blood cell count, reticulocytes analysis, and coagulation test complete blood count test, as these devices are easy to use, provide high level of precision and accuracy for red blood cell counting for evaluation of hematocrit parameters of individuals. Moreover, presence of key companies such as Sysmex Corporation and F. Hoffmann-La Roche Ltd. engaged in research & development and manufacture of innovative blood analyzers boosts the growth of the global market. Furthermore, initiatives taken by public and private organizations are aimed at installing new generation blood analyzers to provide better healthcare facilities and patient care. The relatively stable growth rate of the segment can be ascribed to high replacement rate and limited pipeline of blood analyzers. The hematocrit test meters segment is anticipated to expand at an above average growth rate during the forecast period despite the predominant use of blood analyzers in hematology testing. Preference for hematocrit test meters for hematocrit testing has increased among physicians and other end-users, as these are point-of-care devices and have the potential to provide decentralized patient care and hematocrit test at bedside and faster results than blood analyzers. Additionally, launch of products by Abbott, Nova Biomedical, and EKF Diagnostics are likely to drive the hematocrit test meters segment during the forecast period.

Based on end-user, the global hematocrit test devices market has been classified into hospitals & ambulatory surgical centers, clinics, diagnostic & pathology labs, and others. The hospitals and ambulatory surgical centers segment is expected to dominate the global hematocrit test devices market during the forecast period. In terms of region, the global hematocrit test devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major share of the global hematocrit test devices market in 2017. Europe was another major market for hematocrit test devices in 2017. Developed health care infrastructure and relatively high paying capacity of patients in North America and Europe compared to the developing countries provide assured business growth to new market entrants, which contributed to the high market share of these two regions. High growth rate of the diagnostic industry in India and China and investment made by global companies in China for establishment of sales subsidiaries for providing support and services to customers and to attract new potential customers are expected to propel the hematocrit test devices market in Asia Pacific.

Major players operating in the global hematocrit test devices market include Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthineers (Siemens AG), EKF Diagnostics Holdings plc, Sysmex Corporation, Nova Biomedical, Abbott Laboratories, HORIBA, Ltd., and Boule Diagnostics.

The global hematocrit test devices market has been segmented as follows:

by Product

  • Blood Analyzers
  • Hematocrit Test Meters
  • Others

by End-user

  • Hospitals & Ambulatory Surgical Centers
  • Clinics
  • Diagnostic & Pathology Labs
  • Others

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hematocrit Test Devices Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities

5. Market Outlook
     5.1.Prevalence of Anemia among pregnant women by key countries
     5.2. Prevalence of Anemia by global and WHO region
     5.3. Key Mergers & Acquisitions
     5.4.Recent Product Launches and Approval
     5.5.Comparative Analysis of Hematocrit Test Method
     5.6.Epidemiological Overview of blood related Disease

6. Global Hematocrit Test Devices Market Analysis and Forecasts, by Product 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast, by Product, 2016–2026
            6.3.1. Blood Analyzers
            6.3.2. Hematocrit Test Meters
            6.3.3. Others 
     6.4. Market Attractiveness, by Product

7. Global Hematocrit Test Devices Market Analysis and Forecasts, by End-user 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast, by End-user, 2016–2026
            7.3.1. Hospitals & Ambulatory Surgical Centers
            7.3.2. Clinics 
            7.3.3. Diagnostic & Pathology Labs
            7.3.4. Others 
     7.4. Market Attractiveness, by End-user

8. Global Hematocrit Test Devices Market Analysis and Forecasts, by Region
     8.1. Key Findings
     8.2. Market Value Forecast, by Region
            8.2.1. North America 
            8.2.2. Europe 
            8.2.3. Asia Pacific 
            8.2.4. Latin America 
            8.2.5. Middle East & Africa 
     8.3. Market Attractiveness, by Country/Region

9. North America Hematocrit Test Devices Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
     9.2. Market Value Forecast, by Product, 2016–2026
            9.2.1. Blood Analyzers
            9.2.2. Hematocrit Test Meters
            9.2.3. Others 
     9.3. Market Value Forecast, by End-user, 2016–2026
            9.3.1. Hospitals & Ambulatory Surgical Centers
            9.3.2. Clinics 
            9.3.3. Diagnostic & Pathology Labs
            9.3.4. Others 
     9.4. Market Value Forecast, by Country, 2016–2026
            9.4.1. U.S.
            9.4.2. Canada
     9.5. Market Attractiveness Analysis 
            9.5.1. By Product 
            9.5.2. By End-user 
            9.5.3. By Country

10. Europe Hematocrit Test Devices Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Value Forecast, by Product, 2016–2026
            10.2.1. Blood Analyzers
            10.2.2. Hematocrit Test Meters
            10.2.3. Others 
     10.3. Market Value Forecast, by End-user, 2016–2026
            10.3.1. Hospitals & Ambulatory Surgical Centers
            10.3.2. Clinics 
            10.3.3. Diagnostic & Pathology Labs
            10.3.4. Others 
     10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
            10.4.1. Germany
            10.4.2. U.K.
            10.4.3. France
            10.4.4. Spain
            10.4.5. Italy
            10.4.6. Rest of Europe
     10.5. Market Attractiveness Analysis 
            10.5.1. By Product 
            10.5.2. By End-user 
            10.5.3. By Country/Sub-region

11. Asia Pacific Hematocrit Test Devices Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
     11.2.Market Value Forecast, by Product, 2016–2026
            11.2.1. Blood Analyzers
            11.2.2. Hematocrit Test Meters
            11.2.3. Others 
     11.3.Market Value Forecast, by End-user, 2016–2026
            11.3.1. Hospitals & Ambulatory Surgical Centers
            11.3.2. Clinics 
            11.3.3. Diagnostic & Pathology Labs
            11.3.4. Others 
     11.4.Market Value Forecast, by Country/Sub-region, 2016–2026
            11.4.1. China
            11.4.2. Japan
            11.4.3. India
            11.4.4. Australia & New Zealand
            11.4.5. Rest of Asia Pacific
     11.5.Market Attractiveness Analysis 
            11.5.1. By Product 
            11.5.2. By End-user 
            11.5.3. By Country/Sub-region

12. Latin America Hematocrit Test Devices Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
     12.2.Market Value Forecast, by Product, 2016–2026
            12.2.1. Blood Analyzers
            12.2.2. Hematocrit Test Meters
            12.2.3. Others 
     12.3.Market Value Forecast, by End-user, 2016–2026
            12.3.1. Hospitals & Ambulatory Surgical Centers
            12.3.2. Clinics 
            12.3.3. Diagnostic & Pathology Labs
            12.3.4. Others 
     12.4.Market Value Forecast, by Country/Sub-region, 2016–2026
            12.4.1. Brazil
            12.4.2. Mexico
            12.4.3. Rest of Latin America
     12.5.Market Attractiveness Analysis 
            12.5.1. By Product 
            12.5.2. By End-user 
            12.5.3. By Country/Sub-region

13. Middle East & Africa Hematocrit Test Devices Market Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
     13.2.Market Value Forecast, by Product, 2016–2026
            13.2.1. Blood Analyzers
            13.2.2. Hematocrit Test Meters
            13.2.3. Others 
     13.3.Market Value Forecast, by End-user, 2016–2026
            13.3.1. Hospitals & Ambulatory Surgical Centers
            13.3.2. Clinics 
            13.3.3. Diagnostic & Pathology Labs
            13.3.4. Others 
     13.4.Market Value Forecast, by Country/Sub-region, 2016–2026
            13.4.1. GCC Countries
            13.4.2. South Africa
            13.4.3. Israel
            13.4.4. Rest of Middle East & Africa
     13.5.Market Attractiveness Analysis 
            13.5.1. By Product 
            13.5.2. By End-user 
            13.5.3. By Country/Sub-region

14. Competition Landscape
     14.1.Market Player - Competition Matrix (By Tier and Size of companies)
     14.2.Market Share Analysis, by Company (2016)
     14.3. Competitive Business Strategies
     14.4. Company Profiles
            14.4.1. NIHON KOHDEN CORPORATION
                      14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                      14.4.1.2. Product Portfolio
                      14.4.1.3. SWOT Analysis
                      14.4.1.4. Strategic Overview
                      14.4.1.5. Financial Overview
            14.4.2. F. Hoffmann-La Roche Ltd
                      14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                      14.4.2.2. Product Portfolio
                      14.4.2.3. SWOT Analysis
                      14.4.2.4. Strategic Overview
                      14.4.2.5. Financial Overview
            14.4.3. Danaher Corporation
                      14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                      14.4.3.2. Product Portfolio
                      14.4.3.3. SWOT Analysis
                      14.4.3.4. Strategic Overview
                      14.4.3.5. Financial Overview
            14.4.4. Siemens Healthineers (Siemens AG)
                      14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                      14.4.4.2. Product Portfolio
                      14.4.4.3. SWOT Analysis
                      14.4.4.4. Strategic Overview
                      14.4.4.5. Financial Overview
            14.4.5. EKF Diagnostics Holdings plc
                      14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                      14.4.5.2. Product Portfolio
                      14.4.5.3. SWOT Analysis
                      14.4.5.4. Strategic Overview
                      14.4.5.5. Financial Overview
            14.4.6. Sysmex Corporation
                      14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                      14.4.6.2. Product Portfolio
                      14.4.6.3. SWOT Analysis
                      14.4.6.4. Strategic Overview
                      14.4.6.5. Financial Overview
            14.4.7. Nova Biomedical
                      14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                      14.4.7.2. Product Portfolio
                      14.4.7.3. SWOT Analysis
                      14.4.7.4. Strategic Overview
                      14.4.7.5. Financial Overview
            14.4.8. Abbott Laboratories
                      14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                      14.4.8.2. Product Portfolio
                      14.4.8.3. SWOT Analysis
                      14.4.8.4. Strategic Overview
                      14.4.8.5. Financial Overview
            14.4.9. HORIBA, Ltd.
                      14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                      14.4.9.2. Product Portfolio
                      14.4.9.3. SWOT Analysis
                      14.4.9.4. Strategic Overview
                      14.4.9.5. Financial Overview
            14.4.10. Boule Diagnostics 
                      14.4.6.10. Company Overview (HQ, Business Segments, Employee Strength)
                      14.4.10.2. Product Portfolio
                      14.4.10.3. SWOT Analysis
                      14.4.10.4. Strategic Overview
                      14.4.10.5. Financial Overview

15. Competition Landscape

List of Tables

Table 1: Prevalence of Anemia among Pregnant Women, by Key Countries 
Table 2: Prevalence of anemia among children aged 6-59 months according to Global and WHO region
Table 3: Prevalence of Anemia among all women of reproductive age (15-49) years according to Global and WHO region
Table 4: Comparative Analysis of Hematocrit Test Methods
Table 5: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016-2026
Table 6: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
Table 7: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Region, 2016-2026
Table 8: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 9: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 10: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 13: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 14: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 15: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 16: Asia Pacific Hematocrit Test Devices Market value (US$ Mn) Forecast, by End-user, 2016?2026
Table 17: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 18: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 19: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016?2026
Table 20: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Country/Sub-regions, 2016–2026
Table 21: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures
 
Figure 1: Global Hematocrit Test Devices Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026 
Figure 2: Global Hematocrit Test Devices Market (US$ Mn), by Key Segment, 2017 
Figure 3: Global Hematocrit Test Devices Market (US$ Mn), by Key Segment and Market Share (%), 2017 Figure 4: Global Hematocrit Test Devices Market (US$ Mn), by Market Share (%), 2017
Figure 5: Global Hematocrit Test Devices Market (US$ Mn), by Region (%), 2017 
Figure 6: Global Hematocrit Test Devices, Market Opportunity Map, by Product
Figure 7: Global Hematocrit Test Devices, Market Opportunity Map, by End-user 
Figure 8: Key Industry Evolution/Developments 
Figure 9: Global Hematocrit Test Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026 
Figure 10: Merger and Acquisition of major player from 2010–2018 
Figure 11: Recent Product Launches and Approval 
Figure 12: Annual number of Congenital Heart Defects births in different region 
Figure 13: Estimated Global Prevalence of Chronic Kidney Disease
Figure 14: Estimated Global Prevalence of Leukemia  
Figure 15: Global Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 
Figure 16: Global Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026 
Figure 17: Global Hematocrit Test Devices Market Value Share, by Blood Analyzer Segment, 2016-2026 Figure 18: Global Hematocrit Test Devices Market Value Share, by Hematocrit Test Meters Segment, 2016-2026 
Figure 19: Global Hematocrit Test Devices Market Value Share, by Others, 2016-2026 
Figure 20: Global Hematocrit Test Market Value Share, by End-user, 2017 and 2026
Figure 21: Global Hematocrit Test Market Attractiveness, End-user 2018–2026 
Figure 22: Global Hematocrit Test Market Value Share, by Hospitals & Ambulatory Surgical Centers Segment, 2016-2026 
Figure 23: Global Hematocrit Test Market Value Share, by Clinics Segment, 2016-2026 
Figure 24: Global Hematocrit Test Market Value Share, by Diagnostic & Pathology Labs, 2016-2026 
Figure 25: Global Hematocrit Test Market Value Share, by Others, 2016-2026 
Figure 26: Global Hematocrit Test Devices Market Value Share, by Region, 2017 and 2026 
Figure 27: Global Hematocrit Test Devices Market Attractiveness, Region 
Figure 28: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 29: North America Hematocrit Test Devices Market Value Share, by Country, 2017 and 2026 
Figure 30: North America Hematocrit Test Devices Market Attractiveness, by Country, 2018–2026 
Figure 31: North America Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 
Figure 32: North America Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026 
Figure 33: North America Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026 
Figure 34: North America Hematocrit Test Devices Market Attractiveness, by End-user, 2018–2026 
Figure 35: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026 
Figure 36: Europe Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026 Figure 37: Europe Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 38: Europe Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 
Figure 39: Europe Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026 
Figure 40: Europe Hematocrit Test Devices Balloons Market Value Share, by End-user, 2017 and 2026 Figure 41: Europe Hematocrit Test Devices Market Attractiveness, by End-user, 2018–2026
Figure 42: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016?2026 
Figure 43: Asia Pacific Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026 Figure 44: Asia Pacific Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018?2026
Figure 45: Asia Pacific Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 
Figure 46: Asia Pacific Hematocrit Test Devices Market Attractiveness, by Product, 2018?2026 
Figure 47: Asia Pacific Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026 
Figure 48: Asia Pacific Hematocrit Test Devices Market Attractiveness, by End-user, 2018?2026 
Figure 49: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016?2026 
Figure 50: Latin America Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026 
Figure 51: Latin America Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018?2026 Figure 52: Latin America Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 
Figure 53: Latin America Hematocrit Test Devices Market Attractiveness, by Product, 2018?2026 
Figure 54: Latin America Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026
Figure 55: Latin America Hematocrit Test Devices Market Attractiveness, by End-user, 2018?2026 
Figure 56: Middle East & Africa Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026 
Figure 57: Middle East & Africa Hematocrit Test Devices Market Value Share, by Country/Sub-region, 2017 and 2026 
Figure 58: Middle East & Africa Hematocrit Test Devices Market Attractiveness, by Country/Sub-region, 2018–2026 
Figure 59: Middle East & Africa Hematocrit Test Devices Market Value Share, by Product, 2017 and 2026 Figure 60: Middle East & Africa Hematocrit Test Devices Market Attractiveness, by Product, 2018–2026
Figure 61: Middle East & Africa Hematocrit Test Devices Market Value Share, by End-user, 2017 and 2026 Figure 62: Middle East & Africa Hematocrit Test Devices Market Attractiveness, by End-user, 2018–2026 Figure 63: Global Hematocrit Test Devices Market, Company Share Analysis 
Figure 64: EKF Diagnostics Holdings plc. , Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 65: EKF Diagnostics Holdings plc, Research and Development Expenses, 2013-2017 
Figure 66: EKF Diagnostics Holdings Plc, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 67: EKF Diagnostics Holdings plc. , Breakdown of Net Sales (% Share), by Region (2017 
Figure 68 Sysmex Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 69: Sysmex Corporation, Research and Development Expenses, 2013-2017 
Figure 70: Sysmex Corporation, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 71: Sysmex Corporation, Breakdown of Net Sales (% Share), by Region (2017
Figure 72 Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 73: Abbott Laboratories, Research and Development Expenses, 2013-2017 
Figure 74: Abbott Laboratories, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 75: Abbott Laboratories, Breakdown of Net Sales (% Share), by Region (2017)
Figure 76: Nihon Kohden Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 77: Nihon Kohden Corporation, Research and Development Expenses, 2013-2017 
Figure 78: Nihon Kohden Corporation, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 79: Nihon Kohden Corporation, Breakdown of Net Sales (% Share), by Region (2017)
Figure 80: F. Hoffmann-La Roche Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 81: F. Hoffmann-La Roche Ltd., Research and Development Expenses, 2013-2017 
Figure 82: F. Hoffmann-La Roche Ltd, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 83: F. Hoffmann-La Roche Ltd, Breakdown of Net Sales (% Share), by Region (2017)
Figure 84: Danaher Corporation., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 85: Danaher Corporation, Research and Development Expenses, 2013-2017 
Figure 86: Danaher Corporation, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 87: Danaher Corporation, Breakdown of Net Sales (% Share), by Region (2017)
Figure 88: Siemens Healthineers (Siemens AG), Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 89: Siemens Healthineers (Siemens AG), Research and Development Expenses, 2013-2017 
Figure 90: Siemens Healthineers (Siemens AG), Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 91: Siemens Healthineers (Siemens AG), Breakdown of Net Sales (% Share), by Region (2017)
Figure 92: HORIBA, Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 93: HORIBA, Ltd., Research and Development Expenses, 2013-2017 
Figure 94: HORIBA, Ltd., Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 95: HORIBA, Ltd., Breakdown of Net Sales (% Share), by Region (2017)
Figure 96: Boule Diagnostics, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017 
Figure 97: Boule Diagnostics, Research and Development Expenses, 2013-2017 
Figure 98: Boule Diagnostics, Breakdown of Net Sales (% Share), by Business Segment (2017) 
Figure 99: Boule Diagnostics, Breakdown of Net Sales (% Share), by Region (2017)
Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved